Navneet Majhail, MD

    Navneet Majhail, MD

    Director of the Blood & Marrow Transplant Program at Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio
    • @BldCancerDoc, Or How I Learned to Stop Worrying and Love Twitter Sunday, March 1st, 2015

      I am a recent convert to Twitter. For a while, I was the average Twitter Joe – following a few important people and being followed mainly by my colleagues at Cleveland Clinic (who I suspect chose to follow me more out of courtesy than anything smart I had to say). Ahead of the ASH annual meeting last December, I had [...]

    • To Transplant or Not To Transplant in First Remission? Thursday, January 1st, 2015

      Most patients with newly diagnosed acute myeloid leukemia (AML) will achieve a first complete remission with standard induction chemotherapy. Durable remission or cure can only be attained, though, with further treatment – either post-remission consolidation chemotherapy or hematopoietic cell transplant. Questions about the optimal timing of transplant, as well as which patients will benefit from the procedure, remain an area of debate. In this edition of “Drawing First Blood,” ASH Clinical [...]